[HTML][HTML] Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions

EY Lin, PC Adamson, JD Klausner - Drugs, 2021 - Springer
Neisseria gonorrhoeae is the second most common bacterial sexually transmitted infection
in the world after Chlamydia trachomatis. The pathogen has developed resistance to every …

[HTML][HTML] Current and Emerging Treatment Options for Multidrug Resistant Escherichia coli Urosepsis: A Review

MM Walker, JA Roberts, BA Rogers, PNA Harris… - Antibiotics, 2022 - mdpi.com
Escherichia coli is a versatile commensal and pathogenic member of the human microflora.
As the primary causative pathogen in urosepsis, E. coli places an immense burden on …

Antibiotic management of urinary tract infections in the post-antibiotic era: a narrative review highlighting diagnostic and antimicrobial stewardship

IJ Abbott, TN Peel, KA Cairns, AJ Stewardson - Clinical Microbiology and …, 2023 - Elsevier
Background As one of the most common indications for antimicrobial prescription in the
community, the management of urinary tract infections (UTIs) is both complicated by, and a …

Oral ciprofloxacin activity against ceftriaxone-resistant Escherichia coli in an in vitro bladder infection model

IJ Abbott, E van Gorp, H Cottingham… - Journal of …, 2023 - academic.oup.com
Objectives Pharmacodynamic profiling of oral ciprofloxacin dosing for urinary tract infections
caused by ceftriaxone-resistant Escherichia coli isolates with ciprofloxacin MIC≥ 0.25 mg/L …

Randomized, double-blind, placebo-and positive-controlled crossover study of the effects of tebipenem pivoxil hydrobromide on QT/QTc intervals in healthy subjects

VK Gupta, G Maier, P Eckburg, L Morelli… - Antimicrobial Agents …, 2021 - Am Soc Microbiol
Tebipenem pivoxil hydrobromide (TBP-PI-HBr) is an orally available prodrug of tebipenem
(TBP), a carbapenem with in vitro activity against multidrug-resistant Gram-negative …

New antimicrobial drugs.

P Nikolov, M Georgiev, V Vargulev, R Nikolov - 2022 - cabidigitallibrary.org
The widespread use of antibiotics in unproven bacterial infections has led to the creation of
so-called" superbugs" or bacterial strains that are resistant to a wide range of antimicrobial …

Нови антимикробни лекарства.

П Николов, М Георгиев, В Въргулев… - Medical Review …, 2022 - search.ebscohost.com
The widespread use of antibiotics in unproven bacterial infections has led to the creation of
so-called" superbugs" or bacterial strains that are resistant to a wide range of antimicrobial …